SHREE GANESH REMEDIES
|
SHREE GANESH REMEDIES Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2020 | Mar2019 | |
---|---|---|---|
Profit Before Tax | ₹38 Cr | ₹14 Cr | ₹8.67 Cr |
Adjustment | ₹5.89 Cr | ₹-3.66 Cr | ₹-0.35 Cr |
Changes In working Capital | ₹-5.47 Cr | ₹-5.34 Cr | ₹-14 Cr |
Cash Flow after changes in Working Capital | ₹39 Cr | ₹4.59 Cr | ₹-5.22 Cr |
Cash Flow from Operating Activities | ₹30 Cr | ₹4.59 Cr | ₹-5.22 Cr |
Cash Flow from Investing Activities | ₹-33 Cr | ₹-2.91 Cr | ₹-0.08 Cr |
Cash Flow from Financing Activities | ₹9.84 Cr | ₹-0.48 Cr | ₹-0.18 Cr |
Net Cash Inflow / Outflow | ₹7.28 Cr | ₹1.20 Cr | ₹-5.47 Cr |
Opening Cash & Cash Equivalents | ₹8.66 Cr | ₹1.13 Cr | ₹6.46 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - |
Effect of Foreign Exchange Fluctuations | ₹-0.08 Cr | - | - |
Closing Cash & Cash Equivalent | ₹16 Cr | ₹2.33 Cr | ₹0.99 Cr |
Compare Cashflow Statement of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹949.6 Cr | 6.3% | 12% | 10% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹424,706.0 Cr | 2.3% | 11.7% | 5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,946.0 Cr | -1.6% | 4% | 58.7% | Stock Analytics | |
CIPLA | ₹120,751.0 Cr | 0.8% | 6.2% | -2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,988.0 Cr | 0.7% | 9.8% | 19.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,066.7 Cr | -1% | 2.8% | -8% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | 6.3% |
12% |
10% |
SENSEX | -1.3% |
4.2% |
3.6% |
You may also like the below Video Courses